Hon Hai Precision Industry Co (鴻海精密) chairman Terry Gou (郭台銘) yesterday said a healthcare foundation he created would work with leading research institutes in Taiwan and other nations to combat breast cancer.
The tycoon made the announcement at a news conference held by the Yonglin Healthcare Foundation in Taipei, saying that he has always been determined to “fight breast cancer with technology.”
In pledging to bring together the world’s medical and academic sectors on a single platform to confront the world’s most resilient disease, Gou said the foundation will form an anti-cancer alliance with the National Taiwan University Cancer Center, China’s BGI (華大基因), US-based Nantworks LLC and HudsAlpha Institute for Biotechnology, as well as Taiwan’s biotech sector.
The alliance is to work to determine the genomic code of breast cancer through life science, biotechnology, gene screening and analysis, Gou said.
Gou, whose first wife died of breast cancer in 2005, said “people should turn regret into strength.”
“We believe [we] can bring happiness to humanity,” he said, noting that business opportunities are less important than the chance to live.
“Life is priceless,” he added.
Addressing the alliance, Gou said breast cancer would be its first target, followed by leukemia.
Hon Hai’s cooperation with BGI — known prior to 2008 as the Beijing Genomics Institute — would be like an “industry party” joining hands with a “healthcare party” in the fight against cancer, he said.
BGI, headquartered in Shenzhen, Guangdong Province, is a genome sequencing center. It has been tasked with establishing a Chinese national gene databank and is working to apply its research in genomics to medicine and the germination of agricultural seeds.
At the press conference, BGI president Wang Jian (汪建) said he hopes that in the future, cancer would become a chronic disease that can be controlled.
“Our first objective is to make breast cancer a treatable and controllable disease like liver cancer in the shortest period of time,” Wang said.
Nantworks is a US pharmaceutical company that intends to innovate healthcare by using digital technologies. Also based in the US, HudsonAlpha is a nonprofit institute dedicated to innovation in the field of genomic technology.
Meanwhile, Gou said that he hopes one day the two sides of the Taiwan Strait will jointly establish a special zone for medical care and treatment on Kinmen.
Kinmen “should have a new start as the frontline in the battle against aging, illness and death,” Gou said. “If this is to be achieved in Kinmen, it will begin with health and the promotion of cross-strait peace.”
The rise of the cryptocurrency dogecoin has reached a new level after the token was used to pay for a lunar satellite launch. SpaceX, Elon Musk’s commercial rocket firm, is to embark on a moon voyage next year carrying a so-called cubesat — a mini-satellite used for space research — from Geometric Energy Corp that has been paid for entirely in dogecoin. The development is the latest twist in the saga over the digital token, which started as a joke in 2013, but is now a dominating Internet meme and sitting on a 21,000 percent rally in the past year. Musk has
CAPACITY EXPANSION: Construction of the site, which is to be the firm’s first mRNA production facility outside of Europe, is to begin this year and likely finish in 2023 COVID-19 vaccine maker BioNTech SE yesterday said it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of messenger RNA (mRNA)-based vaccines per year. Construction of the site would start this year, and it could become operational by 2023, the German company said in a statement. “With this planned mRNA production facility, we will increase our overall network capacity, and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world,” BioNTech chief executive Ugur Sahin said. The vaccine produced by BioNTech jointly with Pfizer Inc of
OUTBREAK: About 200 of the airline’s 1,200 pilots are not able to work. Most of them have been quarantined to prevent further infection, but 12 have COVID-19 China Airlines Ltd (CAL,中華航空) yesterday confirmed that it would temporarily reduce its cargo flight services to cope with a pilot shortage, as one-sixth of its pilots have been sidelined by a COVID-19 outbreak. “We are working out a new schedule,” the airline said in a statement after local news media reports on Saturday said that it would be reducing its cargo services from Wednesday, primarily affecting US destinations. CAL declined to give details about its new operating plan, but the reports said that it would be suspending its cargo flights to Dallas Fort Worth International Airport, Hartsfield-Jackson Atlanta International Airport and
The Financial Supervisory Commission (FSC) yesterday fined Citibank Taiwan Ltd (花旗台灣) NT$10 million (US$357,194) and DBS Bank Taiwan (星展台灣) NT$6 million for breaches of the nation’s anti-money laundering (AML) regulations. The NT$10 million fine is the highest penalty that it has imposed on a domestic bank, the commission said. Citibank Taiwan failed to set up a sound mechanism for evaluating clients’ risk of money laundering and for detecting suspicious transactions, Banking Bureau Deputy Director-General Huang Kuang-hsi (黃光熙) told a news conference in New Taipei City. The bank based its AML policies on those of its US-based parent company, Citigroup Inc, but the policies